These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

483 related items for PubMed ID: 33942787

  • 21. Valproate-induced epileptic tonic status.
    Capocchi G, Balducci A, Cecconi M, Pelli MA, Picchiarelli A, Silvestrelli G, Zampolini M.
    Seizure; 1998 Jun; 7(3):237-41. PubMed ID: 9700838
    [Abstract] [Full Text] [Related]

  • 22. Valproate induced non hepatic hyperammonaemic encephalopathy (VNHE)--a study from tertiary care referral university hospital, north India.
    Mehndiratta MM, Mehndiratta P, Phul P, Garg S.
    J Pak Med Assoc; 2008 Nov; 58(11):627-31. PubMed ID: 19024136
    [Abstract] [Full Text] [Related]

  • 23. Risk factors for hyperammonemia in pediatric patients with epilepsy.
    Yamamoto Y, Takahashi Y, Imai K, Mishima N, Yazawa R, Inoue K, Itoh K, Kagawa Y, Inoue Y.
    Epilepsia; 2013 Jun; 54(6):983-9. PubMed ID: 23409971
    [Abstract] [Full Text] [Related]

  • 24. Valproic acid-induced hyperammonemia in neuropsychiatric disorders: a 2-year clinical survey.
    Hosseini H, Shafie M, Shakiba A, Ghayyem H, Mayeli M, Hassani M, Aghamollaii V.
    Psychopharmacology (Berl); 2023 Jan; 240(1):149-156. PubMed ID: 36459199
    [Abstract] [Full Text] [Related]

  • 25. Valproate-related hyperammonemic encephalopathy with generalized suppression EEG: a case report.
    Liu X, Peng X.
    Neurol Sci; 2023 Oct; 44(10):3669-3673. PubMed ID: 37243793
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Hyperammonemia in patients receiving valproic acid in the hospital setting: A retrospective review.
    McMorris T, Chu A, Vu L, Bernardini A.
    Ment Health Clin; 2021 Jul; 11(4):243-247. PubMed ID: 34316420
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Features of Adult Hyperammonemia Not Due to Liver Failure in the ICU.
    Sakusic A, Sabov M, McCambridge AJ, Rabinstein AA, Singh TD, Mukesh K, Kashani KB, Cook D, Gajic O.
    Crit Care Med; 2018 Sep; 46(9):e897-e903. PubMed ID: 29985210
    [Abstract] [Full Text] [Related]

  • 30. Valproate-induced hyperammonemic encephalopathy.
    Verrotti A, Trotta D, Morgese G, Chiarelli F.
    Metab Brain Dis; 2002 Dec; 17(4):367-73. PubMed ID: 12602513
    [Abstract] [Full Text] [Related]

  • 31. Valproate-induced hyperammonemia in juvenile ceroid lipofuscinosis (Batten disease).
    Larsen EP, Ostergaard JR.
    Seizure; 2014 Jun; 23(6):429-34. PubMed ID: 24647346
    [Abstract] [Full Text] [Related]

  • 32. Valproic acid-induced hyperammonemia: Incidence, clinical significance, and treatment management.
    Baddour E, Tewksbury A, Stauner N.
    Ment Health Clin; 2018 Mar; 8(2):73-77. PubMed ID: 29955549
    [Abstract] [Full Text] [Related]

  • 33. Valproate-induced hyperammonemic encephalopathy: an update on risk factors, clinical correlates and management.
    Chopra A, Kolla BP, Mansukhani MP, Netzel P, Frye MA.
    Gen Hosp Psychiatry; 2012 Mar; 34(3):290-8. PubMed ID: 22305367
    [Abstract] [Full Text] [Related]

  • 34. Risk factors for hyperammonemia associated with valproic acid therapy in adult epilepsy patients.
    Yamamoto Y, Takahashi Y, Suzuki E, Mishima N, Inoue K, Itoh K, Kagawa Y, Inoue Y.
    Epilepsy Res; 2012 Sep; 101(3):202-9. PubMed ID: 22542569
    [Abstract] [Full Text] [Related]

  • 35. [Valproate-associated hyperammonemic encephalopathy. Report of one case].
    Young P, Finn BC, Alvarez F, Bruetman JE, Trimarchi H.
    Rev Med Chil; 2007 Nov; 135(11):1446-9. PubMed ID: 18259656
    [Abstract] [Full Text] [Related]

  • 36. Reversible Encephalopathy due to Valproic Acid Induced Hyperammonemia in a Patient with Bipolar I Disorder: A Cautionary Report.
    Patel N, Landry KB, Fargason RE, Birur B.
    Psychopharmacol Bull; 2017 Jan 26; 47(1):40-44. PubMed ID: 28138203
    [Abstract] [Full Text] [Related]

  • 37. Valproate-Induced Hyperammonemic Encephalopathy in General Hospital Patients With One or More Psychiatric Disorders.
    Lewis C, Tesar GE, Dale R.
    Psychosomatics; 2017 Jan 26; 58(4):415-420. PubMed ID: 28411969
    [Abstract] [Full Text] [Related]

  • 38. Hyperammonemic coma after craniotomy: Hepatic encephalopathy from upper gastrointestinal hemorrhage or valproate side effect?: Case report and literature review.
    Guo X, Wei J, Gao L, Xing B, Xu Z.
    Medicine (Baltimore); 2017 Apr 26; 96(15):e6588. PubMed ID: 28403092
    [Abstract] [Full Text] [Related]

  • 39. Levocarnitine for the Treatment of Valproic Acid-Induced Hyperammonemic Encephalopathy in Children: The Experience of a Large, Tertiary Care Pediatric Hospital and a Poison Center.
    Glatstein M, Bonifacio Rino P, de Pinho S, Scolnik D, Pivko-Levi D, Hoyte C.
    Am J Ther; 2019 Apr 26; 26(3):e344-e349. PubMed ID: 29232283
    [Abstract] [Full Text] [Related]

  • 40. Effect of CPS14217C>A genotype on valproic-acid-induced hyperammonemia.
    Yagi M, Nakamura T, Okizuka Y, Oyazato Y, Kawasaki Y, Tsuneishi S, Sakaeda T, Matsuo M, Okumura K, Okamura N.
    Pediatr Int; 2010 Oct 26; 52(5):744-8. PubMed ID: 20456087
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.